Cite
HARVARD Citation
Tanimoto, A. et al. (n.d.). 195PHGCSG1601: A retrospective cohort study of the efficacy and safety of nab-paclitaxel plus gemcitabine (nab-P+GEM) for unresectable locally advanced pancreatic cancer (LAPC). Annals of oncology. p. . [Online].